E-Combretastatin and E-resveratrol structural modifications: Antimicrobial and cancer cell growth inhibitory β-E-nitrostyrenes

Bioorganic and Medicinal Chemistry

Volumn 17, Issue 18, 2009, Pages 6606-6612

  Pettit, Robin K ^a   Pettit, George R ^a   Hamel, Ernest ^b   Hogan, Fiona ^a   Moser, Bryan R ^c   Wolf, Sonja ^a   Pon, Sandy ^a   Chapuis, Jean Charles ^a   Schmidt, Jean M ^a  

^a ARIZONA STATE UNIVERSITY   (United States)

^b Developmental Therapeutics Program   (United States)

^c NATIONAL CENTER FOR AGRICULTURAL UTILIZATION RESEARCH   (United States)

Author keywords

E Nitrostyrene; Anticancer agent; Combretastatin; Resveratrol

Indexed keywords

COMBRETASTATIN; NITROSTYRENE; RESVERATROL; UNCLASSIFIED DRUG;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; CANCER CELL CULTURE; CANDIDA ALBICANS; CELL STRAIN MCF 7; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DRUG SYNTHESIS; ENTEROBACTER CLOACAE; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; FUNGICIDAL ACTIVITY; HUMAN; HUMAN CELL; IC 50; LEUKEMIA P 388; MELANOMA CELL; MICROCOCCUS LUTEUS; MICROTUBULE ASSEMBLY; NEISSERIA GONORRHOEAE; NONHUMAN; STAPHYLOCOCCUS AUREUS; STENOTROPHOMONAS MALTOPHILIA; STREPTOCOCCUS PNEUMONIAE; STRUCTURE ACTIVITY RELATION;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; BACTERIA; BIBENZYLS; CELL LINE, TUMOR; CELL PROLIFERATION; FUNGI; HUMANS; MOLECULAR STRUCTURE; STILBENES; STRUCTURE-ACTIVITY RELATIONSHIP; STYRENES; TUBULIN; TUBULIN MODULATORS;

EID: 69349102810     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmc.2009.07.076     Document Type: Article

References (77)

1. Part 468 in the series 'Antineoplastic Agents'. The previous contribution corresponds to:. Pettit G.R., Melody N., Herald D.L., Schmidt J.M., Pettit R.K., and Chapuis J.-C. Heterocycles 56 (2002) 139
2. For the most current contribution in this series, refer to:. Pettit G.R., Thornhill A.J., Moser B.R., and Hogan F. J. Nat. Prod. 71 (2008) 1561
3. Tron G.C., Pirali T., Sorba G., Pagliai F., Busacca S., and Genazzani A.A. J. Med. Chem. 49 (2006) 3033
4. Pinney K.G., Jelinek C., Edvardsen K., Chaplin D.J., and Pettit G.R. In: Cragg G.M., Kingston D.G.I., and Newman D.J. (Eds). Anticancer Agents from Natural Products (2005), Taylor & Francis, Boca Raton, FL 23-46
5. Cirla A., and Mann J. Nat. Prod. Rep. 20 (2003) 558
6. Pettit G.R. In: Ojima I., Vite G.D., and Altmann K.-H. (Eds). Anticancer Agents: Frontiers in Cancer Chemotherapy (2001), American Chemical Society, Washington, DC 16-42
7. Pettit G.R., Singh S.B., Niven M.L., Hamel E., and Schmidt J.M. J. Nat. Prod. 50 (1987) 119
8. Pettit G.R., Singh S.B., Hamel E., Lin C.M., Alberts D.S., and Garcia-Kendall D. Experientia 45 (1989) 209
9. Chen G., Horsman M.R., Pedersen M., Pang Q., and Stødkilde-Jørgensen H. Acta Oncol. 47 (2008) 1071
10. Yeung S.-C.J., She M., Yang H., Pan J., Sun L., and Chaplin D. J. Clin. Endocrinol. Metab. 92 (2007) 2902
11. Lippert III J.W. Bioorg. Med. Chem. 15 (2007) 605
12. Sheng Y., Hua J., Pinney K.G., Garner C.M., Kane R.R., Prezioso J.A., Chaplin D.J., and Edvardsen K. Int. J. Cancer 111 (2004) 604
13. Salmon H.W., and Siemann D.W. Clin. Cancer Res. 12 (2006) 4090
14. Pettit G.R., and Rhodes M. Anti-Cancer Drug Des. 13 (1998) 183
15. Pettit G.R., and Lippert III J.W. Anti-Cancer Drug Des. 15 (2000) 203
16. Odlo K., Hentzen J., Fournier dit Chabert J., Ducki S., Gani O.A.B.S.M., Sylte I., Skrede M., Flørenes V.A., and Hansen T.V. Bioorg. Med. Chem. 16 (2008) 4829
17. Lee L., Davis R., Vanderham J., Hills P., Mackay H., Brown T., Mooberry S.L., and Lee M. Eur. J. Med. Chem. 43 (2008) 2011
18. Alloatti D., Giannini G., Cabri W., Lustrati I., Marzi M., Ciacci A., Gallo G., Tinti M.O., Marcellini M., Riccioni T., Guglielmi M.B., Carminati P., and Pisano C. J. Med. Chem. 51 (2008) 2708
19. Lin H.-L., Chiou S.-H., Wu C.-W., Lin W.-B., Chen L.-H., Yang Y.-P., Tsai M.-L., Uen Y.-H., Liou J.-P., and Chi C.-W. J. Pharmacol. Exp. Ther. 323 (2007) 365
20. Michels S., Schmidt-Erfurth U., and Rosenfeld P.J. Exp. Opin. Invest. Drugs 15 (2006) 779
21. Escalona-Benz E., Jockovich M.-E., Murray T.G., Hayden B., Hernandez E., Feuer W., and Windle J.J. Invest. Ophthalmol. Visual Sci. 46 (2005) 8
22. Pettit G.R., Toki B., Herald D.L., Verdier-Pinard P., Boyd M.R., Hamel E., and Pettit R.K. J. Med. Chem. 41 (1998) 1688
23. Pettit, G. R.; Melody, N.; Thornhill, A.; Knight, J. C.; Groy, T.; Herald, C. L. J. Nat. Prod., in press.
24. Pettit G.R., Grealish M.P., Jung M.K., Hamel E., Pettit R.K., Chapuis J.-C., and Schmidt J.M. J. Med. Chem. 45 (2002) 2534
25. Orallo F. Curr. Med. Chem. 15 (2008) 1887
26. Zhang F., Sun C., Wu J., He C., Ge X., Huang W., Zou Y., Chen X., Qi W., and Zhai Q. Pharmacol. Res. 57 (2008) 318
27. Louis-Ferdinand R.T., and Fuller G.C. Toxicol. Appl. Pharmacol. 16 (1970) 668
28. Latif N., Mishriky N., Girgis N.S., and Arnos S. Indian J. Chem. 19B (1980) 301
29. Chowdary P.V.R., and Rao M.N.A. Indian J. Pharm. Sci. 49 (1987) 227
30. Berçin E., Gökçe M.U., Abbasoǧlu U., and Noyanalpan N. J. Fac. Pharm. Gazi. 12 (1995) 117
31. Gökçe M., Özçelik B., Bakir G., Karaoǧlu T., Berçin E., and Noyanalpan N. Arzneimittel Forschung 12 (2004) 891
32. Worthen L.R., and Bond H.W. J. Pharm. Sci. 59 (1970) 1185
33. Mikami Y., Yazawa K., Maeda A., Uno J., Kubo A., Saito N., and Kawakami N. J. Antibiot. 44 (1991) 1454
34. Canoira L., Gonzalo Rodriguez J.G., Subirats J.B., Escario J.-A., Jimenez I., and Martinez-Fernandez A.R. Eur. J. Med. Chem. 24 (1989) 39
35. Gullner G., Cserháti T., and Mikite G. Pest. Biochem. Physiol. 39 (1991) 1
36. Milhazes N., Calheiros R., Marquez M.P.M., Garrido J., Cordeiro M.N.D.S., Rodrigues C., Quinteira S., Novais C., Peixe L., and Borges F. Bioorg. Med. Chem. 14 (2006) 4078
37. Schales O., and Graefe H.A. J. Am. Chem. Soc. 74 (1952) 4486
38. Mohan R., Rastogi N., Namboothiri I.N.N., Mobin S.M., and Panda D. Bioorg. Med. Chem. 14 (2006) 8073
39. Carter K.C., Finnon Y.S., Nic Daeid N., Robson D.C., and Waddell R. Immunopharmacol. Immunotoxicol. 24 (2002) 187
40. Kapp S., Quentin I., Tamiru D., Shaheen M., Eger K., and Steinfelder H.J. Biochem. Pharmacol. 65 (2003) 603
41. Werner J.M., Eger K., and Steinfelder H.J. Apoptosis 12 (2007) 235
42. Wang W.-Y., Hsieh P.-W., Wu Y.-C., and Wu C.-C. Biochem. Pharmacol. 74 (2007) 601
43. Park J., and Pei D. Biochemistry 43 (2004) 15014
44. Kim J.H., Kim J.H., Lee G.E., Lee J.E., and Chung I.K. Mol. Pharmacol. 63 (2003) 1117
45. Villar J.A.F.P., Lima F.T.D., Veber C.L., Oliveira A.R.M., Calgarotto A.K., Marangoni S., and da Silva S.L. Toxicon 51 (2008) 1467
46. McNulty J., Steere J.A., and Wolf S. Tetrahedron Lett. 39 (1998) 8013
47. Luzzio F.A. Tetrahedron 57 (2001) 915
48. Pettit G.R., Moser B.R., Boyd M.R., Schmidt J.M., Pettit R.K., and Chapuis J.-C. Anti-Cancer Drug Des. 16 (2001) 185
49. Barnes D.M., Ji J., Fickes M.G., Fitzgerald M.A., King S.A., Morton H.E., Plagge F.A., Preskill M., Wagaw S.H., Wittenberger S.J., and Zhang J. J. Am. Chem. Soc. 124 (2002) 13097
50. Pettit R.K., Hamel E., Verdier-Pinard P., Roberson R.W., Hazen K.C., Pettit G.R., and Crews L.C. Mycoses 45 (2002) 65
51. Pettit G.R., Rhodes M.R., Herald D.L., Chaplin D.J., Stratford M.R.L., Hamel E., Pettit R.K., Chapuis J.-C., and Oliva D. Anti-Cancer Drug Des. 13 (1998) 981
52. Pettit G.R., Rhodes M.R., Herald D.L., Hamel E., Schmidt J.M., and Pettit R.K. J. Med. Chem. 48 (2005) 4087
53. Wipf P., Reeves J.T., Balachandran R., Giuliano K.A., Hamel E., and Day B.W. J. Am. Chem. Soc. 122 (2000) 9391
54. Hamel E. Cell Biochem. Biophys. 38 (2003) 1
55. Louis-Ferdinand R.T., and Fuller G.C. J. Pharm. Sci. 58 (1969) 1155
56. Bai R., Lin C.M., Nguyen N.Y., Liu T.-Y., and Hamel E. Biochemistry 28 (1989) 5606
57. Shan B., Medina J.C., Santha E., Frankmoelle W.P., Chou T.-C., Learned R.M., Narbut M.R., Stott D., Wu P., Jaen J.C., Rosen T., Timmermans P.B.M.W.M., and Beckmann H. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5686
58. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard M2-A6. NCCLS: Wayne, PA, 1997.
59. National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically; Approved Standard M7-A4. NCCLS: Wayne, PA, 1997.
60. National Committee for Clinical Laboratory Standards. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard M27-A. NCCLS: Wayne, PA, 1997.
61. Latif N., Asaad F.M., and Hosni H. Liebigs Ann. Chem. (1987) 495
62. Bovell C.R., Packer L., and Schonbaum R. Arch. Biochem. Biophys. 104 (1964) 458
63. Wang C., and Wang S. Synth. Commun. 32 (2002) 3481
64. Cassel S., Casenave B., Déléris G., Latxague L., and Rollin P. Tetrahedron 54 (1998) 8515
65. Benington F., Morin R.D., and Clark L.C. J. Org. Chem. 20 (1955) 102
66. Benington F., Morin R.D., and Clark L.C. J. Am. Chem. Soc. 76 (1954) 5555
67. Benington F., and Morin R.D. J. Am. Chem. Soc. 73 (1951) 1353
68. Das J.P., Sinha P., and Roy S. Org. Lett. 4 (2002) 3055
69. Benington F., Morin R.D., and Clark L.C. J. Org. Chem. 19 (1954) 11
70. Hamlin K.E., and Weston A.W. J. Am. Chem. Soc. 71 (1949) 2210
71. Noyce W.K., Coleman C.H., and Barr J.T. J. Am. Chem. Soc. 73 (1951) 1295
72. Mayer A.A., and Murphy B.P. Synth. Commun. 15 (1985) 423
73. Rao A.S., Srinivas P.V., Babu K.S., and Rao J.M. Tetrahedron Lett. 46 (2005) 8141
74. Büchi G., and Mak C.-P. J. Org. Chem. 42 (1977) 1784
75. Pettit G.R., and Singh S.B. Can. J. Chem. 65 (1987) 2390
76. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Campbell H., Mayo J., and Boyd M. J. Natl. Cancer Inst. 83 (1991) 757
77. Suffness M., and Douros J. Methods in Cancer Research (1979), Academic, New York 73-126